Identification Generic Name (2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID DrugBank Accession Number DB08007 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID (DB08007) ×  Close Weight Average: 238.2399  Monoisotopic: 238.095356946  Chemical Formula C 11 H 14 N 2 O 4 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Chymotrypsin-like elastase family member 1 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene. Kingdom Organic compounds Super Class Benzenoids Class Benzene and substituted derivatives Sub Class Not Available Direct Parent Benzene and substituted derivatives Alternative Parents Monosaccharides  /  Alpha hydroxy acids and derivatives  /  Ureas  /  Secondary alcohols  /  Monocarboxylic acids and derivatives  /  Carboxylic acids  /  Organopnictogen compounds  /  Organonitrogen compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Carbonyl compounds 
 
 
  show 1 more Substituents Alcohol  /  Alpha-hydroxy acid  /  Aromatic homomonocyclic compound  /  Carbonic acid derivative  /  Carbonyl group  /  Carboxylic acid  /  Carboxylic acid derivative  /  Hydrocarbon derivative  /  Hydroxy acid  /  Monocarboxylic acid or derivatives  /  Monocyclic benzene moiety  /  Monosaccharide  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Secondary alcohol  /  Urea 
 
 
  show 10 more Molecular Framework Aromatic homomonocyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key KGFDIRSBGRVEFZ-SECBINFHSA-N InChI InChI=1S/C11H14N2O4/c14-9(10(15)16)7-13-11(17)12-6-8-4-2-1-3-5-8/h1-5,9,14H,6-7H2,(H,15,16)(H2,12,13,17)/t9-/m1/s1 IUPAC Name (2R)-3-[(benzylcarbamoyl)amino]-2-hydroxypropanoic acid SMILES [H][C@@](O)(CNC(=O)NCC1=CC=CC=C1)C(O)=O References General References Not Available External Links PubChem Compound 24820112 PubChem Substance 99444478 ChemSpider 25057879 PDBe Ligand J54 PDB Entries 2v35 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 1.08 mg/mL ALOGPS logP -0.25 ALOGPS logP -0.19 Chemaxon logS -2.3 ALOGPS pKa (Strongest Acidic) 3.67 Chemaxon pKa (Strongest Basic) -2.1 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 4 Chemaxon Polar Surface Area 98.66 Å 2 Chemaxon Rotatable Bond Count 5 Chemaxon Refractivity 59.67 m 3 ·mol -1 Chemaxon Polarizability 23.78 Å 3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption - 0.5199 Blood Brain Barrier - 0.6474 Caco-2 permeable - 0.7423 P-glycoprotein substrate Non-substrate 0.5908 P-glycoprotein inhibitor I Non-inhibitor 0.9133 P-glycoprotein inhibitor II Non-inhibitor 0.9257 Renal organic cation transporter Non-inhibitor 0.9399 CYP450 2C9 substrate Non-substrate 0.7536 CYP450 2D6 substrate Non-substrate 0.7993 CYP450 3A4 substrate Non-substrate 0.803 CYP450 1A2 substrate Non-inhibitor 0.8787 CYP450 2C9 inhibitor Non-inhibitor 0.885 CYP450 2D6 inhibitor Non-inhibitor 0.945 CYP450 2C19 inhibitor Non-inhibitor 0.8973 CYP450 3A4 inhibitor Non-inhibitor 0.9092 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9743 Ames test Non AMES toxic 0.6994 Carcinogenicity Non-carcinogens 0.927 Biodegradation Ready biodegradable 0.7651 Rat acute toxicity 1.7733 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9446 hERG inhibition (predictor II) Non-inhibitor 0.9112    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Chymotrypsin-like elastase family member 1 Kind Protein Organism Humans Pharmacological action Unknown General Function Serine-type endopeptidase activity Specific Function Acts upon elastin. Gene Name CELA1 Uniprot ID Q9UNI1 Uniprot Name Chymotrypsin-like elastase family member 1 Molecular Weight 27797.995 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:27 / Updated at June 12, 2020 16:52 